PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsRenata
Renata
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
FrovatriptanFrovatriptan2022-04-06
Migraine disorders
MetolazoneMetolazone2022-10-24
Heart failure
,
Hypertension
,
Nephrotic syndrome
,
Edema
MetoprololMetoprolol1995-04-272035
Atrial fibrillation
,
Heart failure
,
Hypertension
,
Myocardial infarction
,
Angina pectoris
,
Atrial flutter
,
Ventricular tachycardia
,
Ventricular fibrillation
,
Supraventricular tachycardia
,
Nephrotic syndrome
,
Edema
,
Glomerulonephritis
,
Liver cirrhosis
PregabalinPregabalin2019-12-262026
Spinal cord injuries,
Epilepsy,
Postherpetic neuralgia,
Fibromyalgia,
Seizures,
Anxiety disorders,
Neuralgia
RosuvastatinRosuvastatin2016-10-312033-2036
Hypercholesterolemia,
Coronary artery disease,
Hypertriglyceridemia,
Hyperlipoproteinemias,
Familial combined hyperlipidemia,
Hyperlipoproteinemia type ii
MemantineMemantine2018-05-072025-2029
Alzheimer disease
RisperidoneRisperidone2008-12-292025-2033
Dementia,
Tourette syndrome,
Schizophrenia,
Bipolar disorder,
Autistic disorder,
Schizophrenia spectrum and other psychotic disorders
ValsartanValsartan2024-08-052023-2036
Heart failure,
Diabetic nephropathies,
Hypertension,
Left ventricular dysfunction,
Coronary artery disease,
Variant angina pectoris,
Nephrotic syndrome,
Edema,
Malignant hypertension
CabergolineCabergoline2026-06-15
Parkinson disease,
Adenoma,
Hyperprolactinemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Solumedrol
uveitis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use